Corentin du Roy, CFA

Managing Director

London, United Kingdom

About Corentin

Corentin du Roy joined HarbourVest in 2003 and focuses on direct co-investments in buyout and growth equity transactions in Europe and around the world. He has been involved with several of HarbourVest’s direct co-investments including Deliveroo, Eaton Towers, Klarna, Marle, GTS Central Europe (acquired by Deutsche Telekom), Omega Pharma (acquired by Perrigo), Minimax, Prosol (Grand Frais), Nycomed (acquired by Takeda), Kiala (acquired by UPS), and Loxam.

He joined the Firm from AXA Investment Managers, where he was an equity and high-yield debt research analyst focusing mainly on the telecom sector.

Fluent in French, Corentin received a BS (with distinction) in Business Administration from Paris IX Dauphine University in 1999 and received the Chartered Financial Analyst designation in 2002.

Explore our expertise

Meet the people of HarbourVest

Learn more

Learn more about HarbourVest

Learn more

HarbourVest Partners, LLC is a registered investment adviser under the Investment Advisers Act of 1940. The information on this site is intended solely for the benefit of firms and companies seeking private equity investment capital by providing general information on our services and philosophy. The material on this site is for informational purposes only and does not constitute an offer or solicitation to purchase any investment solutions or a recommendation to buy or sell a security nor is it to be construed as legal, tax or investment advice. Unless otherwise indicated, any information available through this site is as of the date indicated therein and may not be updated or otherwise revised to reflect information that subsequently becomes available. HarbourVest is under no obligation to update the information contained on this site. Additionally, the material on this site does not constitute a representation that the solutions described therein are suitable or appropriate for any person and HarbourVest does not accept any liability with respect to the information. By using this site you agree to the Terms of Use.